Sepsis News and Research

Latest Sepsis News and Research

Johns Hopkins researchers report on more effective way to spot patients at risk of septic shock

Johns Hopkins researchers report on more effective way to spot patients at risk of septic shock

Coordinated, two-part approach could help reduce hospital-acquired infections

Coordinated, two-part approach could help reduce hospital-acquired infections

California Initiative to Advance Precision Medicine selects two demonstration projects

California Initiative to Advance Precision Medicine selects two demonstration projects

Study shows link between liver-produced molecules, pneumonia susceptibility during sepsis

Study shows link between liver-produced molecules, pneumonia susceptibility during sepsis

CHOP surgeons successfully complete world's first bilateral hand transplant on child

CHOP surgeons successfully complete world's first bilateral hand transplant on child

Biologists identify genetic mechanisms behind anti-inflammatory impact of cortisone

Biologists identify genetic mechanisms behind anti-inflammatory impact of cortisone

UVA partners with MITRE to develop better health data analysis tools

UVA partners with MITRE to develop better health data analysis tools

Scientists discover new variant of streptococcal bacteria that contributes to severe infections

Scientists discover new variant of streptococcal bacteria that contributes to severe infections

University of Liverpool researchers discover common cause of cardiac injury in sepsis patients

University of Liverpool researchers discover common cause of cardiac injury in sepsis patients

Severe burns dramatically change bacteria populations, study finds

Severe burns dramatically change bacteria populations, study finds

Sepsis readmissions have significant impact on health care expenditures in California

Sepsis readmissions have significant impact on health care expenditures in California

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

PAH diagnosis delayed for adult congenital heart disease patients

PAH diagnosis delayed for adult congenital heart disease patients

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

Completing sepsis resuscitation bundle in six hours after diagnosis

Completing sepsis resuscitation bundle in six hours after diagnosis

Researchers discover that extreme exercise can lead to blood poisoning

Researchers discover that extreme exercise can lead to blood poisoning

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.